India’s drug regulator has ordered manufacturers and suppliers of high-risk cough syrup ingredients to register every batch on a digital monitoring system and obtain a system-generated no-objection certificate before distribution. The order…
Sanofi Healthcare has received marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for Qfitlia (fitusiran), a therapy to prevent bleeding in haemophilia patients. The approval covers adults and adolescents aged…
Dr Reddy's Laboratories has received Drugs Controller General of India (DCGI) approval for Zytorvi (toripalimab) in combination with cisplatin and paclitaxel for the first-line treatment of adult patients with unresectable advanced, recurrent,…
The central government is considering a retail-to-wholesale pharmacy licence ratio based on population, disease burden and existing licence density. The proposal was discussed at the 70th Drugs Consultative Committee meeting of the…
The Drugs Controller General of India (DCGI) plans to intensify audits of medical device manufacturing facilities to check compliance with prescribed norms, Dr Rajeev Raghuvanshi announced at the CII Global MedTech Summit.…
The Central Drugs Standard Control Organisation (CDSCO) has directed all state and Union territory drug controllers to ensure that medicines containing enclomiphene and its combinations are not manufactured, sold or distributed in…
Pulse Pharmaceuticals has received approval from the Drugs Controller General of India (DCGI) for its nano-carrier entrapped Vitamin D3 oral dispersion, the company announced on Thursday. Founder and Managing Director K. V.…
The Union health ministry has invited applications for the post of Drugs Controller General of India (DCGI) to head the Central Drugs Standard Control Organisation (CDSCO). The move follows an April 2026…
Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.